Logo image of CBK.DE

COMMERZBANK AG (CBK.DE) Stock Fundamental Analysis

FRA:CBK - Deutsche Boerse Ag - DE000CBK1001 - Common Stock - Currency: EUR

24.28  +0.69 (+2.92%)

Fundamental Rating

3

Taking everything into account, CBK scores 3 out of 10 in our fundamental rating. CBK was compared to 95 industry peers in the Banks industry. CBK may be in some trouble as it scores bad on both profitability and health. CBK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CBK had positive earnings in the past year.
CBK had a negative operating cash flow in the past year.
Of the past 5 years CBK 4 years were profitable.
In multiple years CBK reported negative operating cash flow during the last 5 years.
CBK.DE Yearly Net Income VS EBIT VS OCF VS FCFCBK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B

1.2 Ratios

CBK has a Return On Assets of 0.44%. This is in the lower half of the industry: CBK underperforms 68.42% of its industry peers.
The Return On Equity of CBK (7.15%) is worse than 62.11% of its industry peers.
Industry RankSector Rank
ROA 0.44%
ROE 7.15%
ROIC N/A
ROA(3y)0.37%
ROA(5y)0.12%
ROE(3y)5.88%
ROE(5y)1.6%
ROIC(3y)N/A
ROIC(5y)N/A
CBK.DE Yearly ROA, ROE, ROICCBK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

CBK has a Profit Margin (19.01%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CBK has grown nicely.
CBK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 19.01%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y87.93%
PM growth 5Y25.01%
GM growth 3YN/A
GM growth 5YN/A
CBK.DE Yearly Profit, Operating, Gross MarginsCBK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1

2. Health

2.1 Basic Checks

CBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBK has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CBK has less shares outstanding
The debt/assets ratio for CBK is higher compared to a year ago.
CBK.DE Yearly Shares OutstandingCBK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CBK.DE Yearly Total Debt VS Total AssetsCBK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B 500B

2.2 Solvency

CBK has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CBK (1.59) is better than 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC13.95%
CBK.DE Yearly LT Debt VS Equity VS FCFCBK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CBK.DE Yearly Current Assets VS Current LiabilitesCBK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.19% over the past year.
CBK shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.05% yearly.
Looking at the last year, CBK shows a small growth in Revenue. The Revenue has grown by 3.12% in the last year.
The Revenue has been growing slightly by 6.65% on average over the past years.
EPS 1Y (TTM)17.19%
EPS 3Y103.28%
EPS 5Y28.05%
EPS Q2Q%103.13%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y8.47%
Revenue growth 5Y6.65%
Sales Q2Q%22.71%

3.2 Future

CBK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.35% yearly.
The Revenue is expected to grow by 4.58% on average over the next years.
EPS Next Y6.3%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
EPS Next 5Y13.35%
Revenue Next Year7.97%
Revenue Next 2Y7.63%
Revenue Next 3Y6.92%
Revenue Next 5Y4.58%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBK.DE Yearly Revenue VS EstimatesCBK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
CBK.DE Yearly EPS VS EstimatesCBK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.56, the valuation of CBK can be described as very reasonable.
Based on the Price/Earnings ratio, CBK is valued a bit more expensive than 73.68% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.10, CBK is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.88, the valuation of CBK can be described as reasonable.
66.32% of the companies in the same industry are cheaper than CBK, based on the Price/Forward Earnings ratio.
CBK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.56
Fwd PE 10.88
CBK.DE Price Earnings VS Forward Price EarningsCBK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBK.DE Per share dataCBK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBK does not grow enough to justify the current Price/Earnings ratio.
CBK's earnings are expected to grow with 18.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.84
PEG (5Y)0.41
EPS Next 2Y17.71%
EPS Next 3Y18.63%

4

5. Dividend

5.1 Amount

CBK has a Yearly Dividend Yield of 2.80%.
With a Dividend Yield of 2.80, CBK pays less dividend than the industry average, which is at 5.30. 85.26% of the companies listed in the same industry pay a better dividend than CBK!
CBK's Dividend Yield is comparable with the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

On average, the dividend of CBK grows each year by 11.38%, which is quite nice.
Dividend Growth(5Y)11.38%
Div Incr Years0
Div Non Decr Years1
CBK.DE Yearly Dividends per shareCBK.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

16.84% of the earnings are spent on dividend by CBK. This is a low number and sustainable payout ratio.
The dividend of CBK is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP16.84%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
CBK.DE Yearly Income VS Free CF VS DividendCBK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
CBK.DE Dividend Payout.CBK.DE Dividend Payout, showing the Payout Ratio.CBK.DE Dividend Payout.PayoutRetained Earnings

COMMERZBANK AG

FRA:CBK (5/5/2025, 7:00:00 PM)

24.28

+0.69 (+2.92%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-09 2025-05-09
Inst Owners44.67%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.76B
Analysts78.26
Price Target24.32 (0.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Yearly Dividend0.34
Dividend Growth(5Y)11.38%
DP16.84%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.62%
Min EPS beat(2)32.01%
Max EPS beat(2)83.22%
EPS beat(4)3
Avg EPS beat(4)22.65%
Min EPS beat(4)-35.08%
Max EPS beat(4)83.22%
EPS beat(8)6
Avg EPS beat(8)19.12%
EPS beat(12)8
Avg EPS beat(12)16.16%
EPS beat(16)11
Avg EPS beat(16)55.67%
Revenue beat(2)2
Avg Revenue beat(2)1.84%
Min Revenue beat(2)1.03%
Max Revenue beat(2)2.64%
Revenue beat(4)3
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-1.15%
Max Revenue beat(4)2.64%
Revenue beat(8)6
Avg Revenue beat(8)23.86%
Revenue beat(12)10
Avg Revenue beat(12)25.44%
Revenue beat(16)14
Avg Revenue beat(16)22.89%
PT rev (1m)3.86%
PT rev (3m)24.01%
EPS NQ rev (1m)-6.34%
EPS NQ rev (3m)10.09%
EPS NY rev (1m)0.37%
EPS NY rev (3m)-1.86%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)2.33%
Revenue NY rev (1m)1.79%
Revenue NY rev (3m)2.98%
Valuation
Industry RankSector Rank
PE 11.56
Fwd PE 10.88
P/S 2.22
P/FCF N/A
P/OCF N/A
P/B 0.83
P/tB 0.88
EV/EBITDA N/A
EPS(TTM)2.1
EY8.65%
EPS(NY)2.23
Fwd EY9.19%
FCF(TTM)-18.12
FCFYN/A
OCF(TTM)-17.15
OCFYN/A
SpS10.94
BVpS29.09
TBVpS27.59
PEG (NY)1.84
PEG (5Y)0.41
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 7.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 19.01%
GM N/A
FCFM N/A
ROA(3y)0.37%
ROA(5y)0.12%
ROE(3y)5.88%
ROE(5y)1.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y87.93%
PM growth 5Y25.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.16%
Cap/Sales 8.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC13.95%
ROIC/WACCN/A
Cap/Depr(3y)98.87%
Cap/Depr(5y)65.9%
Cap/Sales(3y)7.2%
Cap/Sales(5y)8.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.19%
EPS 3Y103.28%
EPS 5Y28.05%
EPS Q2Q%103.13%
EPS Next Y6.3%
EPS Next 2Y17.71%
EPS Next 3Y18.63%
EPS Next 5Y13.35%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y8.47%
Revenue growth 5Y6.65%
Sales Q2Q%22.71%
Revenue Next Year7.97%
Revenue Next 2Y7.63%
Revenue Next 3Y6.92%
Revenue Next 5Y4.58%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-211.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-200.16%
OCF growth 3YN/A
OCF growth 5YN/A